Effect of the monascus pigment threonine derivative on regulation of the cholesterol level in mice

Food Chemistry

Volumn 107, Issue 3, 2008, Pages 1078-1085

  Jeun, Jungae ^a   Jung, Heeyong ^a   Kim, Jong Hoon ^a   Kim, Yong Ook ^a   Youn, Sung Hun ^a   Shin, Chul Soo ^a  

^a Yonsei University   (South Korea)

Author keywords

Atherogenic index (AI); HMG CoA reductase inhibitor; Mice in vivo test; Monascus pigment; Threonine derivative

Indexed keywords

AMINO ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THREONINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME INHIBITION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MONASCUS; MOUSE; NONHUMAN;

MONASCUS; MUS;

EID: 36348961824     PISSN: 03088146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodchem.2007.09.021     Document Type: Article

References (35)

1. Albets A.W., Chen J., Curon G., Hunt V., Huff J., Hoffman C., et al. Mevinolin: a highly potent competitive inhibitor of hydroxy-methylglutaryl-coenzyme A reductase and a cholesterol lowering agent. Proceedings of National Academy of Science, USA 77 (1980) 3957-3961
2. Brich A.J., Cassera A., Fitton P., Holker J.S., Smith H., Tomsor G.A., et al. Studies in relation to biosynthesis. Part XXX. Rotrion, monascin and rubropuntatin. Journal of Chemical Society, C (1962) 3583-3586
3. Chen F.C., Manchand P.S., and Whalley W.B. The chemistry of fungi. Part LXIV. The structure of monascin: the relative stereochemistry of the Azaphilones. Journal of Chemical Society, C, Organic Chemistry (1971) 3577-3579
4. Endo A. Monacolin K, a new hypocholesterolemic agent that specifically inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase. Journal of Antibiotics (Japan) 33 (1980) 334-336
5. Fielding B.C., Holker J.S.E., Jones D.E., Powell A.D.G., Richmond K.W., Robertson A., et al. The chemistry of fungi. Part XXXIX. The structure of monascin. Journal of Chemical Society (1961) 4579-4589
6. Folch J., Lee M., and Sloan-Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. Journal of Biological Chemistry 226 (1957) 497-509
7. Fowell A.D.G., Robertson A., and Whalley W.B. Monascorubramine. Journal of Chemical Society 5 (1956) 27-35 Spec. Publ.
8. Friedewald W.T., Levy R.I., and Fedrickson D.S. Estimation of concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clinical Chemistry 18 (1985) 449-502
9. Hadfield J.R., Holder J.S.E., and Stanway D.N. The biosynthesis of fungal metabolites. Part II. The β-oxo-lactone equipments in rubropunctatin and monascorubrin. Journal of Chemical Society 19 (1967) 751-755
10. Haws E.J., and Holker J.S.E. The chemistry of fungi. Part XXXVIII. Journal of Chemical Society (1961) 3820-3829
11. Hiroi T., Shima T., Isobe A., and Kimura S. Studies on the structure of two pigments obtained from Monascus sp. Journal of The Japanese Society of Food Nutrition 28 (1975) 497-502
12. Hiroi T., Shima T., Suzuki T., Tsukioka M., and Ogasawara N. Hyperpigment-production mutant of Monascus anka for solid culture. Agricultural and Biological Chemistry 43 (1979) 1975-1976
13. Izawa S., Haraba N., Watanabe T., Kotokawa N., Yamamoto A., Hayatsu H., et al. Inhibitory effects of food-coloring agents derived from Monascus on the mutagenicity of heterocyclic amines. Journal of Agricultural and Food Chemistry 45 (1997) 3980-3984
14. Jung H., Kim C., Kim K., and Shin C.S. Color characteristics of monascus pigments derived by fermentation with various amino acids. Journal of Agricultural and Food Chemistry 51 (2003) 1302-1306
15. Kim C., Jung H., Kim Y.O., and Shin C.S. Antimicrobial activities of amino acid derivatives of monascus pigments. FEMS Microbiology Letters 264 (2006) 117-124
16. Kim C., Jung H., Kim J.H., and Shin C.S. Effect of monascus pigment derivatives on the electrophoretic mobility of bacteria, and the cell adsorption and antibacterial activities of pigments. Colloids and Surfaces B: Biointerfaces 47 (2006) 153-159
17. Kim J.H., Kim H.J., Kim C., Jung H., Kim Y.O., Ju J.Y., et al. Development of lipase inhibitors from various derivatives of monascus pigment produced by Monasucs fermentation. Food Chemistry 101 (2007) 357-364
18. Kleinsek D.A., Dugan R.E., Baker T.A., and Porter J.W. 3-Hydroxy-3-methylglutaryl coenzyme A reductase from rat liver. Methods in Enzymology 71 (1981) 462-479
19. Krause B.R., and Newton R.S. Lipid-lowering activity of atorbastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models. Atherosclerosis 117 (1995) 237-244
20. Kurono M., Nakanishi K., Shindo K., and Tada M. Biosynthesis of monascorubrin and monascoflavin. Chemical & Pharmaceutical Bulletin (Tokyo) 11 (1963) 359-362
21. Lee C.L., Tsai T.Y., Wang J.J., and Pan T.M. In vivo hypolipidemic effects and safety of low dosage Monascus powder in a hamster model of hyperlipidemia. Applied Microbiology and Biotechnology 70 (2006) 533-540
22. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
23. Lin T.F., Yakushijin K., Büchi G.H., and Demain A.L. Formation of water-soluble Monascus red pigments by biological and semi-synthetic processes. Journal of Industrial Microbiology 9 (1992) 173-179
24. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with folin phenol reagent. Journal of Biological Chemistry 193 (1951) 265-271
25. Manchand P.S., Whalley W.B., and Chen F.C. Isolation and structure of ankaflavin. Phytochemistry 12 (1973) 2531-2534
26. Moll, H. R., & Farr, D. R. (1976). Red pigment and process. U.S. Patent, 3,993,789.
27. Nakawa, N., Watanabe, S., & Kobayashi, J. (1980). Nucleotide treatment of Monascus pigments to produce meat coloring agents. Japanese Patent Kokai, 70,09,682.
28. Reeves P.G. Components of the AIN-93 diets as improvements in the AIN-76A diet. American Society for Nutritional Sciences 127 (1997) 838s-841s
29. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
30. Ross R. Atherosclerosis-an inflammatory disease. New England Journal of Medicine 340 (1999) 115-126
31. Sniderman A.D., St-Pierre A.D., Cantin B., Dagenais G.R., Despres J.-P., and Lamarche B. Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk. The American Journal of Cardiology 91 (2003) 1173-1177
32. Sumioka I., Hayama M., Shimokawa Y., Shiraishi S., and Tokunaga A. Lipid-lowering effect of monascus garlic fermented extract (MGFE) in hyperlipidemic subjects. Hiroshima Journal of Medical Science 55 (2006) 59-64
33. Wei W., Li C., Wang Y., Su H., Zhu J., and Kritchevsky D. Hypolipidemic and anti-atherogenic effects of long-term Cholestin (Monascus purpureus-fermented rice, red yeast rice) in cholesterol fed rabbits. Journal of Nutritional Biochemistry 14 (2003) 314-318
34. Witztum J.L. Drugs used in the treatment of hyperlipoproteinemias. In: Hardman J.G., Limbire L.E., Molinoff P.B., and Ruddon R.W. (Eds). The pharmacological basis of therapeutics. 9th ed. (1996), McGraw-Hill, New York 875-897
35. Yang J.-H., Tseng Y.-H., Lee Y.-L., and Mau J.-L. Antioxidant properties of methanolic extracts from monascal rice. Swiss Society of Food Science and Technology 39 (2006) 740-747